NEWS & MEDIA

Today, International Breast Cancer Day, Olatz Leis, StemTek Therapeutics researcher, has been interviewed by the newspaper 'Tolosaldeko ataria', from Guipuzcoa, Spain to speak about this XXI century disease.      For full article, in basque language only, please check the original source.
Guillermo Yoldi y Eva González-Suárez Laboratorio Transformación y Metástasis, Programa de Epigenética y Biología de Cáncer (PEBC), Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, España. El cáncer de mama es la neoplasia más frecuente en mujeres y por tanto constituye uno de los problemas de salud pública más graves y acuciantes a nivel mundial. La mortalidad en c&a...
The use of genetic reporters for Sox2 activation to track cancer stem cells, published recently in Frontiers Oncology by the team of StemTek, is presented in the science radio show “El Laboratorio de JAL” (RNE-5), conducted by Jose Antonio López Guerrero, Director of the Science Culture Chair at the CBMSO. The audio (spanish) can be heard here.
As a researcher in the field of cancer, you never end learning about this changing and dark enemy. We are always looking forward to unraveling the complexity that underlies every component involved in the initiation, development and evolution of the tumor. We know there is no “cure for cancer”, meaning unilateral cure. Scientists who live trying to defeat it can be compared to The Musketeers, “all for one and one for all”. All against the same enemy which is indeed ...
Contributed by Luciano Vellón, PhD Investigador Adjunto CONICET Laboratorio de Células Madre/Stem Cells Lab. Instituto de Biología y Medicina Experimental (Ibyme)-CONICET Vuelta de Obligado 2490, C.A.B.A, Argentina Teléfono/Phone: +54 11 47832869 Int/Ext 261 e-mail: luciano.vellon@ibyme.conicet.gov.ar, lvellon73@gmail.com   One of the main barriers for the development of cancer stem cells-targeted therapies is the...
Back to top